Provided by Tiger Trade Technology Pte. Ltd.

enVVeno Medical Corp.

10.66
+0.37003.60%
Volume:16.29K
Turnover:174.30K
Market Cap:7.28M
PE:-0.43
High:11.41
Open:10.59
Low:10.30
Close:10.29
52wk High:36.05
52wk Low:8.67
Shares:682.70K
Float Shares:563.60K
Volume Ratio:2.71
T/O Rate:2.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-24.8994
EPS(LYR):-33.0600
ROE:-58.53%
ROA:-36.67%
PB:0.35
PE(LYR):-0.32

Loading ...

enVVeno Medical Corp: Files for Mixed Shelf of Upto $100 Mln -SEC Filing

THOMSON REUTERS
·
Aug 22

enVVeno Medical files $100M mixed securities shelf

TIPRANKS
·
Aug 22

enVVeno Medical: May Offer and Sell Securities for up to $100 Mln - SEC Filing

THOMSON REUTERS
·
Aug 22

enVVeno announces publication of independent health economic study

TIPRANKS
·
Aug 04

enVVeno Cites Journal of Vascular Surgery Study Showing Venous Valve Therapy Saves More than $32,000 Per Patient over Five Years

Reuters
·
Aug 04

enVVeno Medical Q2 EPS $(5.37) Up From $(11.55) YoY

Benzinga Earnings
·
Jul 31

enVVeno Medical Corp: Tavve Pivotal Study Expected to Begin Enrolling Patients During the Second Half of This Year

THOMSON REUTERS
·
Jul 31

enVVeno Medical Corp: Company Enters the Second Half of 2026 with Tailwinds from an FDA Ide Approval

THOMSON REUTERS
·
Jul 31

enVVeno Medical Corp: Cash Runway Extending into the Third Quarter of 2027

THOMSON REUTERS
·
Jul 31

enVVeno Medical: Net Loss Q2 2026 was $3.6 Million, or $5.37 Per Basic and Diluted Share

THOMSON REUTERS
·
Jul 31

enVVeno Medical Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

enVVeno Net Loss Narrows 46% to $3.6 Million in Q2 FY26

Reuters
·
Jul 31

enVVeno Medical Corp Expected to Post a Loss of $4.69 a Share - Earnings Preview

Reuters
·
Jul 28

enVVeno Medical highlights newly issued U.S. patent

TIPRANKS
·
Jul 15

Envveno Medical Wins First US Patent Covering Envve System

Reuters
·
Jul 15

Envveno Medical Wins U.S. Patent Covering Envve Transcatheter Venous Valve System

Reuters
·
Jul 07

Ladenburg Thalmann Upgrades enVVeno Medical to Buy From Neutral, $30 Price Target

MT Newswires Live
·
Jul 06

enVVeno Medical to Present at Webull Corporate Connect Webinar Series

Reuters
·
Jun 22

enVVeno Medical director Francis Duhay disposes of 140 common shares worth $1,442.7

Reuters
·
Jun 13

enVVeno Medical CEO to join Virtual Investor Closing Bell webcast, live Q&A slated

Reuters
·
Jun 02